DRTS Alpha Tau Medical Ltd.

NASDAQ
$14.25

Alpha Tau Medical Ltd. (DRTS) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.14 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +5.6% since its last earnings release on August 10, 2026.

Alpha Tau Medical Missed Consensus Estimates
Monday, August 10, 2026 · 4:01 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 4:00 PM ET
Earnings Whisper
-
vs ($0.14)
Rev est $470K
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $14.27

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Alpha Tau Medical Ltd.

Alpha Tau is an Israeli medical device company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors.

Sector

Healthcare

Industry

Medical Instruments/Supply